Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig S Parzynski

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Plos One|September 18, 2015
Percutaneous Coronary Intervention Utilization and Appropriateness across the United StatesMichael P Thomas, Craig S Parzynski, Jeptha P Curtis, et al.
Health Affairs (Project Hope)|August 10, 2016
Accounting For Patients' Socioeconomic Status Does Not Change Hospital Readmission RatesSusannah M Bernheim, Craig S Parzynski, Leora Horwitz, et al.
Medical Care|December 23, 2017
Defining Multiple Chronic Conditions for Quality MeasurementElizabeth E Drye, Faseeha K Altaf, Kasia J Lipska, et al.
JAMA|November 10, 2015
Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary InterventionNihar R Desai, Steven M Bradley, Craig S Parzynski, et al.
Pharmacoepidemiology and Drug Safety|June 14, 2018
Quantifying the utilization of medical devices necessary to detect postmarket safety differences: A case study of implantable cardioverter defibrillatorsJonathan Bates, Craig S Parzynski, Sanket S Dhruva, et al.
The American Journal of Cardiology|September 1, 2020
Comparison of Mortality and Readmission in Non-Ischemic Versus Ischemic Cardiomyopathy After Implantable Cardioverter-Defibrillator ImplantationAngela Y Higgins, Jenny Bjerre, Craig S Parzynski, et al.
JAMA Cardiology|March 27, 2020
Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart FailureMarat Fudim, Fatima Ali-Ahmed, Craig S Parzynski, et al.
The Journal of Bone and Joint Surgery. American Volume|April 18, 2014
Variation in hospital-level risk-standardized complication rates following elective primary total hip and knee arthroplastyKevin J Bozic, Laura M Grosso, Zhenqiu Lin, et al.
Medical Care|February 27, 2016
Risk-standardized Acute Admission Rates Among Patients With Diabetes and Heart Failure as a Measure of Quality of Accountable Care Organizations: Rationale, Methods, and Early ResultsErica S Spatz, Kasia J Lipska, Ying Dai, et al.
JAMA|July 5, 2018
Association of the US Department of Justice Investigation of Implantable Cardioverter-Defibrillators and Devices Not Meeting the Medicare National Coverage Determination, 2007-2015Nihar R Desai, Paul M Bourdillon, Craig S Parzynski, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Plos One|September 18, 2015
Percutaneous Coronary Intervention Utilization and Appropriateness across the United StatesMichael P Thomas, Craig S Parzynski, Jeptha P Curtis, et al.
Health Affairs (Project Hope)|August 10, 2016
Accounting For Patients' Socioeconomic Status Does Not Change Hospital Readmission RatesSusannah M Bernheim, Craig S Parzynski, Leora Horwitz, et al.
Medical Care|December 23, 2017
Defining Multiple Chronic Conditions for Quality MeasurementElizabeth E Drye, Faseeha K Altaf, Kasia J Lipska, et al.
JAMA|November 10, 2015
Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary InterventionNihar R Desai, Steven M Bradley, Craig S Parzynski, et al.
Pharmacoepidemiology and Drug Safety|June 14, 2018
Quantifying the utilization of medical devices necessary to detect postmarket safety differences: A case study of implantable cardioverter defibrillatorsJonathan Bates, Craig S Parzynski, Sanket S Dhruva, et al.
The American Journal of Cardiology|September 1, 2020
Comparison of Mortality and Readmission in Non-Ischemic Versus Ischemic Cardiomyopathy After Implantable Cardioverter-Defibrillator ImplantationAngela Y Higgins, Jenny Bjerre, Craig S Parzynski, et al.
JAMA Cardiology|March 27, 2020
Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart FailureMarat Fudim, Fatima Ali-Ahmed, Craig S Parzynski, et al.
The Journal of Bone and Joint Surgery. American Volume|April 18, 2014
Variation in hospital-level risk-standardized complication rates following elective primary total hip and knee arthroplastyKevin J Bozic, Laura M Grosso, Zhenqiu Lin, et al.
Medical Care|February 27, 2016
Risk-standardized Acute Admission Rates Among Patients With Diabetes and Heart Failure as a Measure of Quality of Accountable Care Organizations: Rationale, Methods, and Early ResultsErica S Spatz, Kasia J Lipska, Ying Dai, et al.
JAMA|July 5, 2018
Association of the US Department of Justice Investigation of Implantable Cardioverter-Defibrillators and Devices Not Meeting the Medicare National Coverage Determination, 2007-2015Nihar R Desai, Paul M Bourdillon, Craig S Parzynski, et al.
Pageof 6